🇺🇸 FDA
Patent

US 10898737

Substituted piperidine compound and use thereof

granted A61PA61P25/00

Quick answer

US patent 10898737 (Substituted piperidine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P25/00